BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18497944)

  • 1. Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid.
    Matsumoto H; Sakamoto A; Fujiwara M; Yano Y; Shishido-Hara Y; Fujioka Y; Kamma H
    Oncol Rep; 2008 Jun; 19(6):1405-11. PubMed ID: 18497944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
    Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
    Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
    Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
    Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in poorly differentiated papillary thyroid carcinomas.
    Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
    Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.
    Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
    Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSH receptor status of thyroid neoplasms--TaqMan RT-PCR analysis of archival material.
    Sheils OM; Sweeney EC
    J Pathol; 1999 May; 188(1):87-92. PubMed ID: 10398146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
    Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
    J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.
    Zheng H; Wang M; Jiang L; Chu H; Hu J; Ning J; Li B; Wang D; Xu J
    Cancer Res Treat; 2016 Apr; 48(2):698-707. PubMed ID: 26323637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
    Miettinen M; Franssila KO
    Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
    Chen ST; Shieh HY; Lin JD; Chang KS; Lin KH
    J Endocrinol; 2000 May; 165(2):379-89. PubMed ID: 10810302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
    Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
    Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between thyroid-stimulating hormone-peroxiredoxin1 signaling pathway and invasion of papillary thyroid carcinoma].
    Liu X; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 44(4):287-91. PubMed ID: 19558833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.